Stress-management program to reduce heart disease risk in women with HIV
Official title: Adapting and Piloting a Stress Management Intervention to Reduce Cardiovascular Disease Risk Among Women Living With HIV
Run by University of Alabama at Birmingham · NCT06811896 · Data updated 2026-11-12
This program will test whether the SMART stress-management intervention can lower blood pressure and other heart-disease risks for women living with HIV in the Southern US.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 48 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | May 14, 2025 |
| Main results expected | April 2027 |
| Study ends | April 2028 |
| Registry record updated | September 28, 2026 |
| Trial ID | NCT06811896 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking cisgender women aged 18 or older who are HIV-positive, receive care at the recruiting clinic, and are willing and able to attend study visits and provide consent.
✕Probably not a fit
People with severe mental illness, those unwilling or unable to provide informed consent or attend study visits, non-English speakers, and men would not be expected to benefit from this specific program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project adapts the Stress Management and Resiliency Training (SMART) program for cisgender women living with HIV who receive care at a clinic in the Southern US and compares that intervention to usual care. Participants who meet eligibility will be enrolled at the University of Alabama at Birmingham and assigned to receive the SMART intervention or continue with usual care while researchers collect health and stress-related measures. The intervention focuses on resiliency skills, meditation, and techniques to reduce physiological stress responses known to contribute to cardiovascular disease. Outcomes include blood pressure and other markers of cardiovascular risk and stress over the follow-up period.
Why it matters
Potential benefit: If successful, the program could lower blood pressure and reduce long-term cardiovascular risk by improving stress resilience.
How similar studies have gone: The SMART program has demonstrated efficacy in diverse populations for reducing stress responses, but it has not previously been adapted or tested specifically among women living with HIV in the Southern US.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. cis-gender females at least 18 years of age 2. HIV-seropositive and a patient of the recruiting clinic 3. English speaking Exclusion Criteria: 1. severe mental illness 2. not being willing able to provide informed consent 3. not willing or able to attend study visits
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Study coordinator: Jenni Wise, PhD, MSN
- Email: jmwise@uab.edu
- Phone: 2059969459
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Overnight Temperature Regulation to Test Gut Health, Inflammation, and Circadian Rhythms
This study tests whether two weeks of using the Eight Sleep Pod at night can improve gut bacteria balance, lower inflammation, and strengthen daily temperature and blood pressure rhythms in postmenopausal women and age-matched men with poor sleep.
-
Automated Non-Invasive Blood Pressure: Tracking Blood Pressure Changes Using SpO2 Data
This study tests an algorithm that estimates blood pressure changes using data from an SpO2 sensor in patients in the OR, PACU, or ICU who already have invasive BP measured as part of standard care.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Colchicine to see if it reduces coronary artery inflammation in people with HIV
This study tests whether low-dose colchicine can lower inflammation in the coronary arteries of people with HIV who are at high heart-disease risk, compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.